WRLD

Search

#pharmaceutique
BFMTV 2w

Lionel Collet and Jean-François Brochard discussed the rejection of the 2027 budget by the National Assembly and its impact on pharmaceutical innovation in France on the Good Morning Business show on BFM Business. #Budget2027 #InnovationPharma #BFMBusiness (translated)

www.bfmtv.com
Lionel Collet (Haute Autorité de santé) et Jean-François Brochard (Leem) : L'Assemblée nationale a rejeté le budget 2027 - 05/11
2860
L
Le Soir 2w

The pharmaceutical company GSK received 3.4 billion euros in public subsidies between 2019 and 2025, which is 2.5 times more than the 1.4 billion euros in taxes it paid, according to a report from the Athéna Institute. #GSK #AidesPubliques #Emploi (translated)

www.lesoir.be
GSK - GSK a reçu 2,5 fois plus d'aides publiques qu'elle n'a payé d'impôts (Athéna)
2866
L
Le Soir 2w

The German giant Bayer has raised its annual forecasts thanks to the momentum in its pharmaceutical division, despite a net loss in the third quarter due to exceptional write-downs and a decline in the agri-chemicals sector. #Bayer #pharmaceutique #finances (translated)

www.lesoir.be
Bayer rehausse ses prévisions grâce à la pharmacie, malgré une perte nette au 3e trimestre
2868
La Libre.be 3w

GSK announced a 23% decrease in its net profit in the third quarter, leading to a nearly 5% drop in its stock on the London Stock Exchange, due to costs related to a restructuring program while maintaining its financial targets for the year. #GSK #licenciement #pharmaceutique (translated)

www.lalibre.be
Le groupe pharmaceutique GSK annonce un recul du bénéfice net au troisième trimestre
2887
L
Le Soir 3w

GSK announced a 23% decrease in its net profit for the third quarter, amounting to £1.543 billion, due to costs related to a savings program, while maintaining its financial goals for the fiscal year. #GSK #BénéficeNet #Pharmaceutique (translated)

www.lesoir.be
GSK annonce une chute de 23 % de son bénéfice net au troisième trimestre
2887
Jean Marc Morandini 3w
French television host

The author indicated that the European Commission had approved Sanofi's commitments to stop disparaging a competitor's flu vaccine. https://t.co/uFP7jxjCGX #Sanofi #Vaccin #CommissionEuropéenne #FR (translated)

3244
La Libre.be 3w

The pharmaceutical sector is experiencing a return to growth in 2026, supported by investments in American production and the emergence of new treatments, despite previous challenges related to American politics and patent expirations. #Pharmaceutique #Investissement #Santé (translated)

www.lalibre.be
Revue boursière : l’éternel retour de la pharma
2898
La Libre.be 3w

UCB experienced a surge of more than 20% on the Brussels Stock Exchange, supported by significantly better-than-expected results for its treatments and an upward revision of its revenue forecasts. #UCB #BourseBruxelles #Pharmaceutique (translated)

www.lalibre.be
UCB s'envole de plus de 20% à Bruxelles
2900
La Libre.be 4w

The pharmaceutical groups UCB and argenx recorded strong performances, leading to a significant rise in the Bel 20 index in Brussels. #BourseBruxelles #Pharmaceutiques #UCBArgentx (translated)

www.lalibre.be
UCB et argenx brillent à Bruxelles après des solides performances
2788
L
Le Soir 4w

Merck, the German pharmaceutical group, announced the acquisition of the British biotechnology company Silence Therapeutics for approximately 980 million euros, a transaction that is expected to be finalized in the first quarter of 2027. #Merck #SilenceTherapeutics #Biotechnologie (translated)

www.lesoir.be
Merck rachète une biotech britannique pour près d'un milliard d'euros
3022
Bart De Wever 4w
Prime Minister at Government of Belgium

One should not copy-paste the stupidity of others. The Belgian pharmaceutical sector must be protected, not because it suffers from a competitiveness problem, but because of the attitudes of the United States and China, Bart De Wever (N-VA) stated Thursday evening. #GSK #BartDeWever #Pharmaceutique (translated)

Bart De Wever sur la restructuration chez GSK : « Il ne faut pas copier-coller les stupidités des autres »
www.lesoir.be
2912
L
Le Soir 4w

Bart De Wever emphasized during a press conference about the situation at GSK that the Belgian pharmaceutical sector must be protected against unfair competition from the United States and China, and that it is important to create an integrated European market without repeating the mistakes of others. #GSK #BartDeWever #Pharmaceutique (translated)

www.lesoir.be
Bart De Wever sur la restructuration chez GSK : « Il ne faut pas copier-coller les stupidités des autres »
2796
Bart De Wever 4w
Prime Minister at Government of Belgium

Yes, on one hand, there is the American president who is forcing (GSK) to invest in the United States and who refuses to import vaccines again, so companies like GlaxoSmithKline are in difficulty. The Belgian pharmaceutical sector must be protected, not because it suffers from a competitiveness problem, but due to the attitudes of the United States and China, Bart De Wever stated on Thursday evening. #pharmaceutique #GSK #protectionisme (translated)

Sommet européen - GSK: pour De Wever, il faut protéger le secteur pharma vis-à-vis des USA et de la Chine
www.lesoir.be
3145
L
Le Soir 4w

Bart De Wever stated during the European summit that the Belgian pharmaceutical sector must be protected from the United States and China, not due to a lack of competitiveness, but because of unfair competitive practices and investment pressure. #pharmaceutique #GSK #protectionisme (translated)

www.lesoir.be
Sommet européen - GSK: pour De Wever, il faut protéger le secteur pharma vis-à-vis des USA et de la Chine
3029
La Libre.be Oct 15

The article analyzes the repercussions of job cuts at GSK, highlighting that these decisions, although economically motivated, raise essential ethical and human questions in the context of frequent restructuring within large pharmaceutical companies. #GSK #Pharmaceutique #Restructuration (translated)

www.lalibre.be
GSK : une Big Pharma. Surprise ? Pas vraiment !
2680
La Libre.be Oct 15

The Liège pharmaceutical group Hyloris was searched by the authorities regarding documents related to historical issues, while its stock is suspended pending clarification on previous transactions with the Dutch company QliniQ. #Hyloris #Pharmaceutique #Investissement (translated)

www.lalibre.be
Perquisition au sein de la pharma liégeoise Hyloris
2680
L
Le Soir Oct 15

Hyloris confirmed a visit from the authorities to its offices in Liège, where representatives requested access to documents related to previous issues with the FSMA, while the trading of its shares had been suspended on the Brussels Stock Exchange. #Hyloris #Liège #Pharmaceutique (translated)

www.lesoir.be
Hyloris confirme une visite des autorités dans ses bureaux à Liège
2680
La Libre.be Oct 14

GSK is facing a threat of laying off more than 1,200 employees in Belgium, raising concerns about its ability to innovate in the search for new treatments and vaccines in the face of increased competition and industry challenges. #GSK #Pharmaceutique #EmploisMenacés (translated)

www.lalibre.be
Pas de vaccin contre le déclin
2681
La Libre.be Oct 14

The federal government and the Walloon government have asked GSK to minimize the social impact of its restructuring threatening more than 1,200 jobs while emphasizing the importance of preserving the pharmaceutical industry in Belgium. #GSK #emplois #Belgique (translated)

www.lalibre.be
Le gouvernement a demandé à la direction de GSK de limiter au maximum l'impact social
2914
David Clarinval Oct 14

"It is urgent to take measures in the areas of health or taxation if we want to save the Belgian Pharma Valley," reacted Federal Employment Minister David Clarinval on Wednesday after the announcement by the pharmaceutical group GSK of its intention to restructure its activities in Belgium. #GSK #PharmaValley #Licenciements (translated)

Le monde politique réagit aux licenciements chez GSK : “Il est urgent de prendre des mesures si nous voulons sauver la Pharma Valley belge"
www.lalibre.be
2798